Advertisement

Turning Point Therapeutics, Inc. TPTX

Set alert

Price alert · TPTX

All alert types
75.49 +75.49 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
3.81B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-10.54
Beta
-0.19
Short ratio
1.89
Inst. own
92.52%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2022
50-d avg
75.21
200-d avg
46.90
1y target
71.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TPTX has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $1.28MExpenses → Selling, General & Admin: $37.70MExpenses → Research & Development: $86.79MGross Profit → Expenses: $119.00KRevenue → Gross Profit: $119.00KNet Loss → Expenses: $123.09MOther Income$1.28MGross Profit$119.00KNet Loss$123.09MExpenses$124.48MSelling, General & Admin$37.70MResearch & Development$86.79MRevenue$119.00K

Period ending Jun 30, 2022 · select a line to chart its history

Income statement

TPTX quarterly income statement
119.00K
119.00K
119.00K
124.48M
86.79M
37.70M
-124.36M
-123.09M
-123.09M
-123.09M
-123.09M
-2.48
-2.48
-2.48
-123.09M
-123.09M
49.70M
49.70M

Balance sheet

TPTX quarterly balance sheet
290.15M
290.15M
528.14M
528.14M
831.67M
9.63M
843.34M
4.05M
4.94M
49.42M
890.00K
50.31M
-714.26M
-6.91M
793.02M
793.02M
11.67M
4.94M
890.00K
7.93M

Cash flow

TPTX quarterly cash flow
1.32M
8.97M
-19.39M
-1.53M
8.97M
76.94M
78.47M
-105.30M
17.31M
Advertisement